ITI Pharma and Healthcare Fund Regular vs HDFC Pharma and Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
HDFC Pharma and Healthcare Fund - Regular (G)
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹231 Cr | ₹2011 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 08 Nov 2021 | 04 Oct 2023 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare Index |
| Turn Over | % | % |
| Expense Ratio | 2.35 | 2.14 |
| Manager | Rohan Korde | Dhruv Muchhal |
| ISIN Code | INF00XX01BL5 | INF179KC1HL7 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Month | -2.35% | -0.51% |
| 6 Month | -5.47% | 0.13% |
| 1 Year | -4.74% | 7.17% |
| 3 Year | 18.11% | - |
| 5 Year | - | - |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 6 Month | -3.43% | 0.43% |
| 1 Year | -3.45% | 9.81% |
| 3 Year | 11.48% | - |
| 5 Year | - | - |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Year | 17.45% | 26.32% |
| 3 Year | 19.42% | - |
| 5 Year | - | - |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Standard Deviation | 14.52% | - |
| Sharp | 0.82% | - |
| Beta | 0.9% | - |
| Alpha | -1.59% | - |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Name | Rohan Korde | Dhruv Muchhal |
| Total AUM | ₹4626 Cr | ₹520687 Cr |
| Funds Managed | 10 | 40 |
| ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 2.71 | 1.61 |
| Large Cap | 48.48 | 38.75 |
| Small Cap | 27.6 | 32.62 |
| Mid Cap | 21.21 | 27.02 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 2.71 | 1.61 |
| Pharmaceuticals & Biotechnology | 69.73 | 75.22 |
| Healthcare Services | 22.3 | 22.28 |
| Industrial Manufacturing | 0.97 | - |
| Insurance | 1.26 | - |
| Healthcare Equipment & Supplies | 0.91 | 0.89 |
| Fertilizers & Agrochemicals | 1.31 | - |
| Chemicals & Petrochemicals | 0.81 | - |
Top Comparisons
Nippon India Large Cap Fund- Growth Plan -Growth Option
3Y Returns18.79%
Edelweiss Large Cap Fund - Regular Plan - Growth Option
3Y Returns15.31%
WhiteOak Capital Multi Cap Fund - Regular (G)
3Y Returns0%
Aditya Birla Sun Life Multi-Cap Fund-Regular Growth
3Y Returns16.6%
ICICI Prudential Corporate Bond Fund - Growth
3Y Returns7.73%
Canara Robeco CorpoRate Bond Fund - Regular Plan - Growth Option
3Y Returns6.44%
ICICI Prudential Focused Equity Fund - Growth
3Y Returns22.94%
Bandhan Focused Fund - Regular Plan - Growth
3Y Returns18.91%